Rhythm Pharmaceuticals CFO Disposes $702K in Stock as Company Posts Strong Revenue Trends
Rhythm Pharmaceuticals Chief Financial Officer Hunter C. Smith sold 6,628 shares of Rhythm common stock on February 4 and 5, 2026, for roughly $702,744. The disposals were carried out under a Rule 10b5-1 plan adopted in February 2025. The company has reported preliminary revenue gains for 2025 and several firms raised price targets after encouragin…